Therapeutic Excellence & Advanced Finished Dosage Forms (FDF)
Finecure’s manufacturing scale is matched by the breadth of its therapeutic impact. The company formulates and manufactures Finished Dosage Forms (FDF) across 15+ therapeutic categories — capabilities proven daily through a domestic Branded Rx portfolio prescribed by over 40,000 healthcare practitioners.
Diverse FDF Manufacturing Capabilities
Operating five specialised manufacturing blocks, Finecure delivers [capacity - use the company-profile figure] annually with consistent, zero-defect quality.

- Oral Solid Dosages (OSD)
High-volume tablets and capsules, including specialised ER/SR profiles. - Liquid & Dry Syrups
Precision-filled pediatric and adult suspension formulations. - Sterile Injectables
Produced in a inspected to PIC/S GMP standards facility. - Powders, granules and sachets
Nutraceutical or liquid dosage lines - Creams and gels
Dedicated topical lines
Key Therapeutic Verticals

- Anti-Infectives & Beta-Lactams
Driven by a 100% physically isolated Clavulanic block, ensuring the stability of moisture-sensitive antibiotics. - Cephalosporins
A dedicated, PIC/S-approved cephalosporin injectable plant, segregated under GMP. - Cardiology & Diabetology
Advanced chronic-care formulations for hypertension and glycemic management. - Gastroenterology
High-stability OSD technologies for optimal bioavailability in gastrointestinal health. - Syrups, suspensions and dry syrups
Dedicated liquid dosage lines
Isolated Clavulanic Block
A 100% physically isolated beta-lactam block with independent HVAC, holding relative humidity below 20% — the condition moisture-sensitive Amoxicillin + Clavulanate requires for commercial-scale stability across tablets, dispersible tablets, and dry syrups. Why it matters: a de-risked, high-barrier supply line for one of the world’s most in-demand antibiotic combinations.
PIC/S-Approved Cephalosporin Plant
A separate, dedicated, PIC/S-approved cephalosporin injectable plant — segregated under GMP as cephalosporin manufacture legally requires, and independent of the Clavulanic block. Aseptic liquid and dry-powder vials for critical-care and institutional sterile supply. Why it matters: cephalosporins demand fully segregated manufacture; a dedicated, approved plant de-risks regulated-market sterile contracts.